Dopamine agonists exert Nurr1‑inducing effect in peripheral blood mononuclear cells of patients with Parkinson’s disease

Chinese Medical Journal

Volumn 128, Issue 13, 2015, Pages 1755-1760

  Zhang, Li Min ^a   Sun, Cong Cong ^a,b   Mo, Ming Shu ^a   Cen, Luan ^a   Wei, Lei ^a,c   Luo, Fei Fei ^a,d   Li, Yi ^a,e   Li, Guo Fei ^f   Zhang, Si Yun ^a,g   Yi, Li ^g   Huang, Wei ^h   Liu, Zhuo Lin ^a   Le, Wei Dong ^i,j   Xu, Ping Yi ^a,k  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

^e JINAN UNIVERSITY   (China)

^f HENAN UNIVERSITY   (China)

^g PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^h NANCHANG UNIVERSITY   (China)

ⁱ SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^j DALIAN MEDICAL UNIVERSITY   (China)

^k GUANGZHOU MEDICAL UNIVERSITY   (China)

more..

Author keywords

Dopamine agonists; Nurr1; Parkinson s disease

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; PIRIBEDIL; PRAMIPEXOLE; NR4A2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HOEHN AND YAHR SCALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PARKINSON DISEASE; RNA, MESSENGER; YOUNG ADULT;

EID: 84933513901     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.159349     Document Type: Article

References (31)

1. Zetterström RH, Williams R, Perlmann T, Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res 1996;41:111-20.
2. Bäckman C, Perlmann T, Wallén A, Hoffer BJ, Morales M. A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res 1999;851:125-32.
3. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997;276:248-50.
4. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 1998;95:4013-8.
5. Singh NK, Banerjee BD, Bala K, Chhillar M, Chhillar N. Gene-gene and gene-environment interaction on the risk of Parkinson’s disease. Curr Aging Sci 2014;7:101-9.
6. Pan-Montojo F, Reichmann H. Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology. Transl Neurodegener 2014;3:10.
7. Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 1999;126:4017-26.
8. Schimmel JJ, Crews L, Roffler-Tarlov S, Chikaraishi DM. 4.5 kb of the rat tyrosine hydroxylase 5’ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors. Brain Res Mol Brain Res 1999;74:1-14.
9. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 2001;76:1565-72.
10. Le W, Conneely OM, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, et al. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp Neurol 1999;159:451-8.
11. Le W, Conneely OM, He Y, Jankovic J, Appel SH. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem 1999;73:2218-21.
12. Eells JB, Lipska BK, Yeung SK, Misler JA, Nikodem VM. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 2002;136:267-75.
13. Bäckman C, You ZB, Perlmann T, Hoffer BJ. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 2003;143:95-100.
14. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 2005;191:154-62.
15. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003;33:85-9.
16. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, et al. Decreased NURR1 gene expression in patients with Parkinson’s disease. J Neurol Sci 2008;273:29-33.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
18. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord 2004;19:1020-8.
19. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
20. Sun CC, Luo FF, Wei L, Lei M, Li GF, Liu ZL, et al. Association of serum uric acid levels with the progression of Parkinson’s disease in Chinese patients. Chin Med J 2012;125:583-7.
21. Tetradis S, Bezouglaia O, Tsingotjidou A. Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 2001;142:663-70.
22. Martinez-Gonzalez J, Badimon L. The NR4A subfamily of nuclear receptors: New early genes regulated by growth factors in vascular cells. Cardiovasc Res 2005;65:609-18.
23. Mages HW, Rilke O, Bravo R, Senger G, Kroczek RA. NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. Mol Endocrinol 1994;8:1583-91.
24. Zhao D, Desai S, Zeng H. VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: Role in VEGF-induced angiogenesis. Int J Cancer 2011;128:2602-12.
25. Myers SA, Eriksson N, Burow R, Wang SC, Muscat GE. Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol 2009;309:101-8.
26. Maheux J, Ethier I, Rouillard C, Lévesque D. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: Implication for their mechanism of action. J Pharmacol Exp Ther 2005;313:460-73.
27. Ojeda V, Fuentealba JA, Galleguillos D, Andrés ME. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. J Neurosci Res 2003;73:686-97.
28. Pan T, Xie W, Jankovic J, Le W. Biological effects of pramipexole on dopaminergic neuron-associated genes: Relevance to neuroprotection. Neurosci Lett 2005;377:106-9.
29. Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol 2002;450:203-14.
30. Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson’s disease and related disorders. J Comp Neurol 2006;494:495-514.
31. Kim SY, Choi KC, Chang MS, Kim MH, Kim SY, Na YS, et al. The dopamine D2 receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. J Neurosci 2006;26:4567-76.